The future use of pathogen-inactivated platelet concentrates

C. P. Engelfriet, H. W. Reesink, Harvey G. Klein, James P. AuBuchon, Ronald G. Strauss, Tom Krusius, Tiina Mäki, Paolo Rebulla, Claes F. Högman, Folke Knutson, Magdalena Letowska, Ebbe Dickmeiss, M. Winter, G. Henn, E. Menichetti, H. C Wolfgang R Mayr, Peter Flanagan, Carmen Martin-Vega, Ll Massuet, Silvano WendelPetr Turek, C. K. Lin, Tsunekatsu Shirato

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)54-66
Number of pages13
JournalVox Sanguinis
Volume85
Issue number1
DOIs
StatePublished - Jul 2003
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Cite this

Engelfriet, C. P., Reesink, H. W., Klein, H. G., AuBuchon, J. P., Strauss, R. G., Krusius, T., Mäki, T., Rebulla, P., Högman, C. F., Knutson, F., Letowska, M., Dickmeiss, E., Winter, M., Henn, G., Menichetti, E., Mayr, H. C. W. R., Flanagan, P., Martin-Vega, C., Massuet, L., ... Shirato, T. (2003). The future use of pathogen-inactivated platelet concentrates. Vox Sanguinis, 85(1), 54-66. https://doi.org/10.1046/j.1423-0410.2003.00315.x